BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol 2017; 23(35): 6500-6515 [PMID: 29085200 DOI: 10.3748/wjg.v23.i35.6500]
URL: https://www.wjgnet.com/2307-8960/full/v23/i35/6500.htm
Number Citing Articles
1
Hyun Jin Song, Nakyung Jeon, Patrick Squires. The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2020; 76(10): 1437 doi: 10.1007/s00228-020-02927-8
2
Aries Chavira, Pedro Belda-Ferre, Tomasz Kosciolek, Farhana Ali, Pieter C. Dorrestein, Rob Knight. Concepts and Principles of PharmacologyHandbook of Experimental Pharmacology 2019; 260: 301 doi: 10.1007/164_2019_317
3
Michelle Doll, Alexandre R. Marra, Anucha Apisarnthanarak, Amal Saif Al-Maani, Salma Abbas, Victor D. Rosenthal. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious DiseasesInternational Journal of Infectious Diseases 2021; 102: 188 doi: 10.1016/j.ijid.2020.10.039
4
Felipe Leonardo Fagundes, Quélita Cristina Pereira, Melina Luzzi Zarricueta, Raquel de Cássia dos Santos. Malvidin Protects against and Repairs Peptic Ulcers in Mice by Alleviating Oxidative Stress and InflammationNutrients 2021; 13(10): 3312 doi: 10.3390/nu13103312
5
Luisa F. Duque-Buitrago, Antonio Tornero-Martínez, Verónica Loera-Castañeda, Rosalva Mora-Escobedo. Use of food and food-derived products in the treatment of gastritis: A systematic reviewCritical Reviews in Food Science and Nutrition 2022; : 1 doi: 10.1080/10408398.2021.2024131
6
Janet K. Sluggett, Samanta Lalic, Sarah M. Hosking, Brett Ritchie, Jennifer McLoughlin, Terry Shortt, Leonie Robson, Tina Cooper, Kelly A. Cairns, Jenni Ilomäki, Renuka Visvanathan, J. Simon Bell. Root Cause Analysis to Identify Medication and Non-Medication Strategies to Prevent Infection-Related Hospitalizations from Australian Residential Aged Care ServicesInternational Journal of Environmental Research and Public Health 2020; 17(9): 3282 doi: 10.3390/ijerph17093282
7
Heartburn-Related Internet Searches and Trends of Interest across Six Western Countries: A Four-Year Retrospective Analysis Using Google Ads Keyword PlannerInternational Journal of Environmental Research and Public Health 2019; 16(23): 4591 doi: 10.3390/ijerph16234591
8
Min Hyuk Choi, Dokyun Kim, Seok Hoon Jeong, Hyuk Min Lee, Heejung Kim. Risk Factors of Severe Clostridioides difficile Infection; Sequential Organ Failure Assessment Score, Antibiotics, and RibotypesFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.900681
9
Xiaoqun Lv, Jun Zhang, Miao Jiang, Yujuan Liu, Weifang Ren, Zhonghong Fang. Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbiditiesMedicine 2019; 98(13): e15004 doi: 10.1097/MD.0000000000015004
10
Bojana Milenković, Vesna Šuljagić, Aneta Perić, Viktorija Dragojević-Simić, Olivera Tarabar, Milomir Milanović, Vesna Putić, Diana Tomić, Branislava Miljković, Sandra Vezmar Kovačević. Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort studyEuropean Journal of Hospital Pharmacy 2022; 29(e1): e15 doi: 10.1136/ejhpharm-2020-002574
11
Michael Simonov, Erica A. Abel, Melissa Skanderson, Amir Masoud, Ronald G. Hauser, Cynthia A. Brandt, Francis P. Wilson, Loren Laine. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney StonesClinical Gastroenterology and Hepatology 2021; 19(1): 72 doi: 10.1016/j.cgh.2020.02.053
12
Joshua Bell, Jasmine Vatani, Micheal Raad, Lawal Labaran, Varun Puvanesarajah, Hamid Hassanzadeh. Clostridium difficile Infection Following Spine SurgerySpine 2020; 45(22): 1572 doi: 10.1097/BRS.0000000000003627
13
Yoon Hee Park, Jong Mi Seong, Soyeon Cho, Hye Won Han, Jae Youn Kim, Sook Hee An, Hye Sun Gwak. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort studyJournal of Gastroenterology 2019; 54(12): 1052 doi: 10.1007/s00535-019-01598-2
14
Lukas Macke, Christian Schulz, Leandra Koletzko, Peter Malfertheiner. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studiesAlimentary Pharmacology & Therapeutics 2020; 51(5): 505 doi: 10.1111/apt.15604
15
Myung Jin Song, Seok Kim, Dachung Boo, Changhyun Park, Sooyoung Yoo, Ho Il Yoon, Young-Jae Cho. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unitScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-98069-7
16
Annie S Hong, Wen Yuan Yu, Jenny M Hong, Chad L Cross, Mohamed Azab, Gordon Ohning, Mahendran Jayaraj. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysisJournal of Gastroenterology and Hepatology 2020; 35(6): 932 doi: 10.1111/jgh.14958
17
Phung Anh Nguyen, Mohaimenul Islam, Cooper J Galvin, Chih-Cheng Chang, Soo Yeon An, Hsuan-Chia Yang, Chih-Wei Huang, Yu-Chuan (Jack) Li, Usman Iqbal. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumoniaInternational Journal for Quality in Health Care 2020; 32(5): 292 doi: 10.1093/intqhc/mzaa041
18
Umer Farooq, Zahid Ijaz Tarar, Faisal Kamal, Adnan Malik, Joseph Bresnahan, Ayokunle T. Abegunde. Is acid suppression associated with the increased length of stay in diabetic ketoacidosis patients? A nationwide analysisJournal of Internal Medicine 2022;  doi: 10.1111/joim.13466
19
Wei-Te Hung, Ying-Hock Teng, Shun-Fa Yang, Han-Wei Yeh, Ying-Tung Yeh, Yu-Hsun Wang, Ming-Yung Chou, Ming-Chih Chou, Chi-Ho Chan, Chao-Bin Yeh. Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort StudyJournal of Clinical Medicine 2018; 7(9): 252 doi: 10.3390/jcm7090252
20
Melina Luzzi Zarricueta, Felipe Leonardo Fagundes, Quélita Cristina Pereira, Simone Queiroz Pantaleão, Raquel de Cássia dos Santos. Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico ApproachPharmaceutics 2022; 14(3): 565 doi: 10.3390/pharmaceutics14030565
21
Toshiaki Komatsu, Ryosuke Inagaki, Shintaro Azuma, Shunya Mochida, Yosuke Sato, Yoshinori Seto, Shin Nihonyanagi, Takayuki Hoshiyama, Tatsuhiko Wada, Yoko Takayama, Koichiro Atsuda. Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospitalJournal of Infection and Chemotherapy 2022; 28(7): 884 doi: 10.1016/j.jiac.2022.03.006
22
Jianyi Yin, Roy Elias, Lan Peng, Nicholas Levonyak, Annapoorani Asokan, Alana Christie, Nisa Kubiliun, James Brugarolas, Hans J. Hammers. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell CarcinomaClinical Genitourinary Cancer 2022;  doi: 10.1016/j.clgc.2022.01.017
23
Yun-Jie Ma, Zong-Xun Cao, Yong Li, Shun-Yi Feng. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysisWorld Journal of Gastroenterology 2019; 25(21): 2675-2682 doi: 10.3748/wjg.v25.i21.2675
24
Gloria M. Aguirre-García, Elvira Garza-González, Rayo Morfin-Otero, Adrián Camacho-Ortiz. Clostridioides difficile infections among healthcare workersAmerican Journal of Infection Control 2020; 48(10): 1270 doi: 10.1016/j.ajic.2020.01.012
25
Neeraj Puro, Reena Joseph, Ferhat D. Zengul, Kenneth J. Cochran, Bernard C. Camins, Midge Ray. Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic ReviewJournal for Healthcare Quality 2020; 42(3): 127 doi: 10.1097/JHQ.0000000000000236
26
Claire Kennedy, Joanne M. Bargman. Nolph and Gokal's Textbook of Peritoneal Dialysis2021; : 1 doi: 10.1007/978-3-319-90760-4_20-1
27
Jessica S. Tischendorf, Mary J. Knobloch, Jackson S. Musuuza, Nasia Safdar. Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill PatientsJournal for Healthcare Quality 2020; 42(4): e39 doi: 10.1097/JHQ.0000000000000209
28
Chia-Jung Kuo, Cheng-Yu Lin, Chun-Wei Chen, Chiu-Yi Hsu, Sen-Yung Hsieh, Cheng-Tang Chiu, Wey-Ran Lin. Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control StudyJournal of Personalized Medicine 2021; 11(11): 1063 doi: 10.3390/jpm11111063
29
Trusha Nana, Chanelle Moore, Tom Boyles, Adrian J. Brink, Joy Cleghorn, Lesley M. Devenish, Briette du Toit, Ernst S. Fredericks, Molebogeng R. Lekalakala-Mokaba, Caroline Maluleka, Muhammad N. Rajabally, Gary Reubenson, Liliwe Shuping, Karin Swart, Khine Swe Swe Han, Jeannette Wadula, Justyna Wojno, Warren Lowman. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guidelineSouthern African Journal of Infectious Diseases 2020; 35(1) doi: 10.4102/sajid.v35i1.219
30
Sirasa Ruangritchankul, Nancye M Peel, Leila Shafiee Hanjani, Leonard C Gray. <p>The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting</p>Clinical Interventions in Aging 2020; : 865 doi: 10.2147/CIA.S252432
31
Yun Hong, Ziqi Ye, Zhe Gao, Yuefeng Rao. Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospitalJournal of International Medical Research 2020; 48(10): 030006052095472 doi: 10.1177/0300060520954729
32
Yafet Mamo, Michael H Woodworth, Tiffany Wang, Tanvi Dhere, Colleen S Kraft. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile InfectionClinical Infectious Diseases 2018; 66(11): 1705 doi: 10.1093/cid/cix1097
33
Thomas Frieling. Gastroösophageale RefluxkrankheitJournal für Gastroenterologische und Hepatologische Erkrankungen 2019; 17(2): 28 doi: 10.1007/s41971-019-0047-0
34
Khalid Al Sulaiman, Kholoud Al Aamer, Alaa Al Harthi, Saud Jaser, Abdulrahman Al Anazi, Sultan Al Subaie, Ramesh Vishwakarma. Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort studyPharmacology Research & Perspectives 2020; 8(4) doi: 10.1002/prp2.624
35
Shinako Miyano, Nobuaki Michihata, Ken-Ei Sada, Kazuaki Uda, Hiroki Matsui, Kiyohide Fushimi, Masaomi Nangaku, Hideo Yasunaga. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case–control studyRheumatology 2021; 60(4): 1717 doi: 10.1093/rheumatology/keaa594
36
Hee-Eun Hong, A-Sol Kim, Mi-Rae Kim, Hae-Jin Ko, Min Kyu Jung. Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic StudiesCancers 2020; 12(8): 2220 doi: 10.3390/cancers12082220
37
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba. The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studiesGut 2021; 70(11): 2076 doi: 10.1136/gutjnl-2020-321609
38
Hyun Jin Song, Haesuk Park, Susan Park, Jin-Won Kwon. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control studyPharmacoepidemiology and Drug Safety 2019; 28(6): 830 doi: 10.1002/pds.4773
39
Angela Horvath, Vanessa Stadlbauer. Das Mikrobiom als Drehscheibe für Nebenwirkungen der Protonenpumpenhemmer-TherapieZentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie 2021; 146(02): 165 doi: 10.1055/a-1312-7587
40
Eric A. Pasman, Bruce Ong, Claire P. Witmer, Cade M. Nylund. Proton Pump Inhibitors in Children: the Good, the Bad, and the UglyCurrent Allergy and Asthma Reports 2020; 20(8) doi: 10.1007/s11882-020-00926-4
41
Sae Aratani, Takeshi Matsunobu, Takahiro Kawai, Hirotake Suzuki, Norihiro Usukura, Kimihiro Okubo, Yukinao Sakai. Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Very Short-term Use of Proton Pump InhibitorThe Keio Journal of Medicine 2021; 70(1): 19 doi: 10.2302/kjm.2020-0008-CR
42
S. Valette, A. Dory, B. Gourieux, J.-C. Weber. Évaluation de l’implantation d’un processus de dé-prescription des inhibiteurs de la pompe à protons (IPP) à l’aide d’un algorithme au sein d’un service de médecine interneLa Revue de Médecine Interne 2021; 42(8): 535 doi: 10.1016/j.revmed.2020.11.014
43
Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for DeprescribingJournal of the American Medical Directors Association 2021; 22(1): 15 doi: 10.1016/j.jamda.2020.09.046
44
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani. Intestinal Barrier in Human Health and DiseaseInternational Journal of Environmental Research and Public Health 2021; 18(23): 12836 doi: 10.3390/ijerph182312836
45
N. Sopena, N. Freixas, F. Bella, J. Pérez, A. Hornero, E. Limon, F. Gudiol, M. Pujol. Impact of a training program on the surveillance of Clostridioides difficile infectionEpidemiology and Infection 2019; 147 doi: 10.1017/S0950268819001080
46
Mo Li, Corina Behrenbruch, Alex Wong, Vinna An. Megacolon following ileostomy reversal due to Clostridium difficile ANZ Journal of Surgery 2020; 90(9): 1769 doi: 10.1111/ans.16124
47
Loai Albarqouni, Ray Moynihan, Justin Clark, Anna Mae Scott, Anne Duggan, Chris Del Mar. Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic reviewBMC Family Practice 2021; 22(1) doi: 10.1186/s12875-021-01369-0
48
Hildenia B. R. Nogueira, Cecília L. Costa, Conceição S. Martins, Maria Luana G. S. Morais, Carlos Quesada-Gómez, Cibele B. M. Carvalho, Eliane de Oliveira Ferreira, Gerly Anne de Castro Brito. Infection with Clostridioides difficile ribotype 046 in a paediatric liver transplant patient Access Microbiology 2021; 3(10) doi: 10.1099/acmi.0.000268
49
S. Knecht, T. Schmidt-Wilcke. Der zweite Blick: praktische diagnostische und therapeutische Checks in der rehabilitativen NeurologieDer Nervenarzt 2020; 91(4): 324 doi: 10.1007/s00115-020-00887-z
50
Kate N. Wang, J. Simon Bell, Edwin C. K. Tan, Julia F. M. Gilmartin-Thomas, Michael J. Dooley, Jenni Ilomäki. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case–Control StudyDrugs & Aging 2019; 36(11): 1027 doi: 10.1007/s40266-019-00704-6
51
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati, Stuart Jon Spechler. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology 2022; 117(1): 27 doi: 10.14309/ajg.0000000000001538
52
Syeda Sahra, Mohammad Abureesh, Shivantha Amarnath, Motasem Alkhayyat, Rawan Badran, Abdullah Jahangir, Vivek Gumaste. <i>Clostridioides difficile </i>infection in liver cirrhosis patients: A population-based study in United StatesWorld Journal of Hepatology 2021; 13(8): 926-938 doi: 10.4254/wjh.v13.i8.926
53
Laura Biganzoli, Saverio Cinieri, Rossana Berardi, Rebecca Pedersini, Amelia McCartney, Alessandro Marco Minisini, Elena Rota Caremoli, Simon Spazzapan, Emanuela Magnolfi, Antonella Brunello, Emanuela Risi, Raffaella Palumbo, Silvana Leo, Marco Colleoni, Sara Donati, Sabino De Placido, Laura Orlando, Mirco Pistelli, Veronica Parolin, Anna Mislang, Dimitri Becheri, Fabio Puglisi, Giuseppina Sanna, Elena Zafarana, Luca Boni, Giuseppe Mottino. EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancerBreast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01319-1
54
Hongbai Wang, Qipeng Luo, Yinan Li, Liang Zhang, Xie Wu, Fuxia Yan. Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-AnalysisFrontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00456
55
Russell Roark, Michael Sydor, Ahmed T. Chatila, Shifa Umar, Ramiro De La Guerra, Mohammad Bilal, Praveen Guturu. Management of gastroesophageal reflux diseaseDisease-a-Month 2020; 66(1): 100849 doi: 10.1016/j.disamonth.2019.02.002
56
Ahmed Al-Marhabi, Ahmed Hashem, Bader Faiyaz Zuberi, Charles Onyekwere, Imran Lodhi, Mohamed Mounir, Saad Alkhowaiter, Sameer Al Awadhi, Vasudevan G. Naidoo, Yasser Hamada. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)Expert Review of Gastroenterology & Hepatology 2022; 16(3): 217 doi: 10.1080/17474124.2022.2043744
57
Rhonda L. Stuart, Caroline Marshall, Glenys Harrington, Louisa Sasko, Mary-Louise McLaws, John Ferguson. ASID/ACIPC position statement – Infection control for patients with Clostridium difficile infection in healthcare facilitiesInfection, Disease & Health 2019; 24(1): 32 doi: 10.1016/j.idh.2018.10.001
58
Geoffroy Desbuissons, Lucile Mercadal. Use of proton pump inhibitors in dialysis patients: a double-edged sword?Journal of Nephrology 2021; 34(3): 661 doi: 10.1007/s40620-020-00808-y
59
Mohamed Saad, Hassan Mitwally. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case ReportJournal of Pharmacy Practice 2020; 33(5): 700 doi: 10.1177/0897190019838681
60
Jeffrey A. Berinstein, Calen A. Steiner, Katelin J. Roth, Emily Briggs, Krishna Rao, Peter D. R. Higgins. Association of Household Pets, Common Dietary Factors, and Lifestyle Factors with Clostridium difficile InfectionDigestive Diseases and Sciences 2021; 66(1): 206 doi: 10.1007/s10620-020-06123-7
61
F. Prechter, A. Stallmach. Clostridium difficile auf der IntensivstationMedizinische Klinik - Intensivmedizin und Notfallmedizin 2020; 115(2): 81 doi: 10.1007/s00063-018-0459-1
62
Sibel Bolukcu, IsmailNecati Hakyemez, BilgeSumbul Gultepe, Gulay Okay, Bulent Durdu, MelihaMeric Koc, Turan Aslan. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficileSaudi Journal of Gastroenterology 2019; 25(6): 0 doi: 10.4103/sjg.SJG_44_19
63
Danial Haris Shaikh, Harish Patel, Rezwan Munshi, Haozhe Sun, Shehriyar Mehershahi, Ahmed Baiomi, Ahmed Alemam, Usman Pirzada, Iqra Nawaz, Kamrun Naher, Siddarth Hanumanthu, Suresh Nayudu. Patients with <i>Clostridium difficile</i> infection and prior appendectomy may be prone to worse outcomesWorld Journal of Gastrointestinal Surgery 2021; 13(11): 1436-1447 doi: 10.4240/wjgs.v13.i11.1436
64
Giovanni Bruno, Piera Zaccari, Giulia Rocco, Giulia Scalese, Cristina Panetta, Barbara Porowska, Stefano Pontone, Carola Severi. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarifiedWorld Journal of Gastroenterology 2019; 25(22): 2706-2719 doi: 10.3748/wjg.v25.i22.2706
65
Ronald Hills, Benjamin Pontefract, Hillary Mishcon, Cody Black, Steven Sutton, Cory Theberge. Gut Microbiome: Profound Implications for Diet and DiseaseNutrients 2019; 11(7): 1613 doi: 10.3390/nu11071613
66
Hannah Donnelly, Tom Nolan. Dyspepsia: When to refer for endoscopyInnovAiT: Education and inspiration for general practice 2019; 12(3): 144 doi: 10.1177/1755738018785984
67
Shih‐Lun Teng, Che‐Han Hsu, Chia‐Chun Hsu, Jeng‐Shiann Shin, Jen‐Chieh Huang. Association of gastric acid suppressants with the development of spontaneous bacterial peritonitis in cirrhotic patients with ascitesAdvances in Digestive Medicine 2020; 7(3): 139 doi: 10.1002/aid2.13164
68
Vesna Šuljagić, Bojana Milenković, Aneta Perić, Dragutin Jovanović, Vesna Begović-Kuprešanin, Srđan Starčević, Aleksandar Tomić, Sandra Vezmar Kovačević, Viktorija Dragojević-Simić. Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort studyLibyan Journal of Medicine 2020; 15(1): 1708639 doi: 10.1080/19932820.2019.1708639
69
Mai Alalawi, Seba Aljahdali, Bashaer Alharbi, Lana Fagih, Raghad Fatani, Ohoud Aljuhani. Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factors Annals of Saudi Medicine 2020; 40(4): 305 doi: 10.5144/0256-4947.2020.305
70
Hye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, Seung Joo Kang, Jong Kyu Park, Eun Jeong Gong, Jeong Eun Shin, Hyun Chul Lim, Sang Kil Lee, Da Hyun Jung, Yoon Jin Choi, Seung In Seo, Joon Sung Kim, Jung Min Lee, Beom Jin Kim, Sun Hyung Kang, Chan Hyuk Park, Suck Chei Choi, Joong Goo Kwon, Kyung Sik Park, Moo In Park, Tae Hee Lee, Seung Young Kim, Young Sin Cho, Han Hong Lee, Kee Wook Jung, Do Hoon Kim, Hee Seok Moon, Hirota Miwa, Chien-Lin Chen, Sutep Gonlachanvit, Uday C Ghoshal, Justin C Y Wu, Kewin T H Siah, Xiaohua Hou, Tadayuki Oshima, Mi-Young Choi, Kwang Jae Lee. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux DiseaseJournal of Neurogastroenterology and Motility 2021; 27(4): 453 doi: 10.5056/jnm21077
71
Wilson Jose Mesquita, Craig M. Kline, Patricia Vernier, Anna M. Ledgerwood, Charles E. Lucas. Failure of gastric prophylaxis against stress bleeding reflects inadequate pH controlSurgery 2018; 164(4): 733 doi: 10.1016/j.surg.2018.05.019
72
Jiyoun Song, Bevin Cohen, Philip Zachariah, Jianfang Liu, Elaine L. Larson. Temporal change of risk factors in hospital-acquired Clostridioides difficile infection using time-trend analysisInfection Control & Hospital Epidemiology 2020; 41(9): 1048 doi: 10.1017/ice.2020.206
73
Benedetta Govoni, Amedeo Zurlo, Roberto De Giorgio, Rosario Cultrera, Stefano Volpato. Clostridium difficile infection in a Geriatric Care Unit: clinical characteristics and prognosisJournal of Gerontology and Geriatrics 2020; 69(1): 1 doi: 10.36150/2499-6564-419
74
Michael Mazzeffi, Samuel Galvagno, Clare Rock. Prevention of Healthcare-associated Infections in Intensive Care Unit PatientsAnesthesiology 2021; 135(6): 1122 doi: 10.1097/ALN.0000000000004017
75
David A Katzka, Peter J Kahrilas. Advances in the diagnosis and management of gastroesophageal reflux diseaseBMJ 2020; : m3786 doi: 10.1136/bmj.m3786
76
Abidemi S. Adenikinju, James E. Feng, Clementine A. Namba, Tyler A. Luthringer, Claudette M. Lajam. Gastrointestinal Complications Warranting Invasive Interventions Following Total Joint ArthroplastyThe Journal of Arthroplasty 2019; 34(11): 2780 doi: 10.1016/j.arth.2019.06.026
77
Thakul Rattanasuwan, Adonice P. Khoury, Alex M. Ebied. Proton Pump Inhibitors: for What and for How LongSN Comprehensive Clinical Medicine 2020; 2(6): 719 doi: 10.1007/s42399-020-00268-2
78
Seung In Seo, Seng Chan You, Chan Hyuk Park, Tae Joon Kim, You Sang Ko, Yerim Kim, Jong Jin Yoo, Jinseob Kim, Woon Geon Shin. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine‐2 receptor antagonists: A 15‐year hospital cohort study using a common data model Journal of Gastroenterology and Hepatology 2020; 35(8): 1325 doi: 10.1111/jgh.14983
79
Kuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, Ting-Yu Yen, Hsien-Meng Chen, Yu-Hsin Chiu, Yu-Lung Hsu, Chun-Hsiang Chiu, Ting-Yi Su, Wan-Lin Tsai, Wei-Yu Chen, Chung-Hao Huang, Huei-Min Hung, Ling-Ju Huang, Hong-Jie Kuo, Pei-Chin Lin, Ching-Hsiang Yang, Pi-Lien Hong, Susan Shin-Jung Lee, Yao-Shen Chen, Yung-Ching Liu, Li-Ming Huang. Recommendations and guidelines for the treatment of Clostridioides difficile infection in TaiwanJournal of Microbiology, Immunology and Infection 2020; 53(2): 191 doi: 10.1016/j.jmii.2020.02.002
80
Y N Yarushina, G B Kolotova, V A Rudnov, V A Bagin. Risk Factors for diarrhea associated with Clostridium difficile in patients at a clinical hospitalTerapevticheskii arkhiv 2019; 91(11): 20 doi: 10.26442/00403660.2019.11.000337
81
Lisa W.M. Leung, Mark M. Gallagher. Letter in reply to Gianni et al on “Prevention, diagnosis, and management of atrioesophageal fistula”Pacing and Clinical Electrophysiology 2020; 43(11): 1417 doi: 10.1111/pace.14012
82
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk. Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trialsBritish Journal of Clinical Pharmacology 2022; 88(4): 1551 doi: 10.1111/bcp.15103
83
Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI)Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2019; 62(7): 906 doi: 10.1007/s00103-019-02959-1
84
Lovepreet Singh, Kapil Kanwar, Ajeet Pal Singh. Proton pump inhibitors: An incisive reviewIndian Journal of Pharmacy and Pharmacology 2021; 8(2): 116 doi: 10.18231/j.ijpp.2021.019
85
Justin Putnam, Allan B. Wolfson, Shahriar Zehtabshi. Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill PatientsAcademic Emergency Medicine 2020; 27(7): 634 doi: 10.1111/acem.13914
86
Daniel De-la-Rosa-Martinez, Frida Rivera-Buendía, Patricia Cornejo-Juárez, Bertha García-Pineda, Carolina Nevárez-Luján, Diana Vilar-Compte. Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in MexicoAmerican Journal of Infection Control 2022;  doi: 10.1016/j.ajic.2022.02.011
87
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, Jee Myung Yang, Su Jin Jeong, Sun Joon Moon, Joo Young Cho, In Kyung Yoo, Dong Keon Yon. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matchingGut 2021; 70(1): 76 doi: 10.1136/gutjnl-2020-322248
88
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in SwedenJournal of Gastroenterology 2020; 55(4): 453 doi: 10.1007/s00535-019-01652-z
89
Ying Lian Xiao, Li Ya Zhou, Xiao Hua Hou, Yan Qing Li, Duo Wu Zou, Min Hu Chen. Chinese expert consensus on gastroesophageal reflux disease in 2020Journal of Digestive Diseases 2021; 22(7): 376 doi: 10.1111/1751-2980.13028
90
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effectsAnnals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
91
Jason Laird. Magnetic sphincter augmentation device placement for treatment of gastroesophageal refluxJournal of the American Academy of Physician Assistants 2020; 33(12): 30 doi: 10.1097/01.JAA.0000721664.47053.0e
92
Florian Prechter, Andreas Stallmach. Clostridium difficile auf der IntensivstationWiener klinisches Magazin 2020; 23(5): 210 doi: 10.1007/s00740-020-00354-0
93
Yuquan Rao, Ruifeng Zeng, Xuebin Jiang, Jun Li, Xiaocou Wang. The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical StudiesFrontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00329
94
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade, Romain Coriat. Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?La Presse Médicale 2019; 48(5): 503 doi: 10.1016/j.lpm.2019.02.011
95
Megan Garland, Andrew J. Hryckowian, Martina Tholen, Kristina Oresic Bender, William W. Van Treuren, Sebastian Loscher, Justin L. Sonnenburg, Matthew Bogyo. The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDICell Reports Medicine 2020; 1(1): 100005 doi: 10.1016/j.xcrm.2020.100005
96
Jamie L. Wagner, Kayla R. Stover, Allison M. Bell, Katie E. Barber. Risk factors for development of initial Clostridioides difficile infectionJournal of Global Antimicrobial Resistance 2021; 25: 18 doi: 10.1016/j.jgar.2021.02.012
97
Vanessa Lang, Katrin Gunka, Jan Rudolf Ortlepp, Ortrud Zimmermann, Uwe Groß. Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile InfectionFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.840846
98
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez, Peter J. Kahrilas. Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitorsAlimentary Pharmacology & Therapeutics 2021; 54(2): 129 doi: 10.1111/apt.16407
99
Arthur Laquière, Felix Trottier-Tellier, Romina Urena-Campos, Pascal Lienne, Laurence Lecomte, Maria Katsogiannou, Guillaume Penaranda, Christian Boustière, Masanao Nakamura. Evaluation of Antireflux Mucosectomy for Severe Gastroesophageal Reflux Disease: Medium-Term Results of a Pilot StudyGastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/1606944
100
Domagoj Segregur, Talia Flanagan, James Mann, Andrea Moir, Eva M. Karlsson, Matthias Hoch, David Carlile, Sakina Sayah-Jeanne, Jennifer Dressman. Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These ChangesJournal of Pharmaceutical Sciences 2019; 108(11): 3461 doi: 10.1016/j.xphs.2019.06.021
101
Tien-En Chang, Yi-Shin Huang, Chin-Lin Perng, Yi-Hsiang Huang, Ming-Chih Hou. Use of proton pump inhibitors and the risk of hepatocellular carcinomaJournal of the Chinese Medical Association 2019; 82(10): 756 doi: 10.1097/JCMA.0000000000000157
102
Travis J. Kochan, Michelle S. Shoshiev, Jessica L. Hastie, Madeline J. Somers, Yael M. Plotnick, Daniela F. Gutierrez-Munoz, Elissa D. Foss, Alyxandria M. Schubert, Ashley D. Smith, Sally K. Zimmerman, Paul E. Carlson, Philip C. Hanna, Craig D. Ellermeier. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological ConditionsmSphere 2018; 3(5) doi: 10.1128/mSphere.00335-18
103
Alexa R. Gale, Matthew Wilson. Gastrointestinal Emergencies2019; : 353 doi: 10.1007/978-3-319-98343-1_101
104
Mirela Nicoleta Voicu, Florica Popescu, Dan Nicolae Florescu, Ion Rogoveanu, Adina Turcu-Stiolica, Dan Ionut Gheonea, Vlad Florin Iovanescu, Sevastita Iordache, Sergiu Marian Cazacu, Bogdan Silviu Ungureanu. Clostridioides difficile Infection among Cirrhotic Patients with Variceal BleedingAntibiotics 2021; 10(6): 731 doi: 10.3390/antibiotics10060731
105
Peia Lee, David Fike, Hui Yang, Ronald G. Hall, Steven Pass, Carlos A. Alvarez. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort studyExpert Review of Clinical Pharmacology 2021; 14(3): 399 doi: 10.1080/17512433.2021.1890582
106
John P. Haran, Doyle V. Ward, Shakti K. Bhattarai, Ethan Loew, Protiva Dutta, Amanda Higgins, Beth A. McCormick, Vanni Bucci. The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiomeGut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1897209
107
Ronald D. Hills Jr., Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton, Cory R. Theberge. Gut Microbiome: Profound Implications for Diet and DiseaseKompass Nutrition & Dietetics 2022; : 1 doi: 10.1159/000523712
108
Lindsay M. Daniels, Wesley D. Kufel. Clinical review of Clostridium difficile infection: an update on treatment and preventionExpert Opinion on Pharmacotherapy 2018; 19(16): 1759 doi: 10.1080/14656566.2018.1524872
109
Carlos E. Figueroa Castro, L. Silvia Munoz-Price. Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile InfectionCurrent Treatment Options in Infectious Diseases 2019; 11(1): 12 doi: 10.1007/s40506-019-0179-y
110
Giulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, Laura Saccomanno, Dino Vaira. Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux disease (NERD): a prospective observational studyInternal and Emergency Medicine 2020; 15(7): 1265 doi: 10.1007/s11739-020-02309-z
111
Christopher T. Campbell, Margaret Oates Poisson, Elizabeth Oates Hand. An Updated Review of Clostridium difficile Treatment in PediatricsThe Journal of Pediatric Pharmacology and Therapeutics 2019; 24(2): 90 doi: 10.5863/1551-6776-24.2.90
112
John Papastergiou, Michelle Donnelly, Terence Yuen, Wilson Li, Bart van den Bemt. Community pharmacy–based H. pylori screening for patients with uninvestigated dyspepsiaCanadian Pharmacists Journal / Revue des Pharmaciens du Canada 2020; 153(2): 101 doi: 10.1177/1715163520903065
113
Kaneez Fatima, Talal Almas, Shan Lakhani, Arshia Jahangir, Abdullah Ahmed, Ayra Siddiqui, Aiman Rahim, Saleha Ahmed Qureshi, Zukhruf Arshad, Shilpa Golani, Adeena Musheer. The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-AnalysisTropical Medicine and Infectious Disease 2022; 7(3): 37 doi: 10.3390/tropicalmed7030037
114
Kevin T. Lynch, Christopher L. Cramer, William J. Kane, Traci Hedrick, Charles Friel, Sudheer Vemuru, Sook C. Hoang. A history of Clostridioides difficile infection portends infection recurrence and worse outcomes after stoma reversalSurgery 2021; 170(1): 55 doi: 10.1016/j.surg.2020.12.032
115
Stelian Stefanita Mogoanta, Stefan Paitici, Carmen Aurelia Mogoanta. Abdominal Surgery - A Brief Overview2021;  doi: 10.5772/intechopen.97739
116
Jacek Czepiel, Mirosław Dróżdż, Hanna Pituch, Ed J. Kuijper, William Perucki, Aleksandra Mielimonka, Sarah Goldman, Dorota Wultańska, Aleksander Garlicki, Grażyna Biesiada. Clostridium difficile infection: reviewEuropean Journal of Clinical Microbiology & Infectious Diseases 2019; 38(7): 1211 doi: 10.1007/s10096-019-03539-6